Cargando…

Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes

Activation of the complement system by IgA was investigated with immune complexes containing a mouse IgA myeloma protein with specificity for phosphorylcholine linked to bovine serum albumin (PC-BSA). These IgA anti-PC-BSA immune complexes activated the alternative complement pathway in mouse and gu...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1982
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186569/
https://www.ncbi.nlm.nih.gov/pubmed/7054357
_version_ 1782145972231471104
collection PubMed
description Activation of the complement system by IgA was investigated with immune complexes containing a mouse IgA myeloma protein with specificity for phosphorylcholine linked to bovine serum albumin (PC-BSA). These IgA anti-PC-BSA immune complexes activated the alternative complement pathway in mouse and guinea pig serum, while human complement was not affected. The activation proceeded with consumption of C3 but little or no consumption of C5. C3 did not bind to the IgA immune complexes during complement activation although it did bind covalently to IgG immune complexes. It is suggested that IgA immune complexes do not supply a suitable surface for C3 binding and effective alternative pathway convertase assembly; therefore, cleavage is limited and occurs primarily in the fluid phase. Without C3 binding, C5 cleavage does not occur nor can the alternative pathway activation proceed to the amplification step.
format Text
id pubmed-2186569
institution National Center for Biotechnology Information
language English
publishDate 1982
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21865692008-04-17 Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes J Exp Med Articles Activation of the complement system by IgA was investigated with immune complexes containing a mouse IgA myeloma protein with specificity for phosphorylcholine linked to bovine serum albumin (PC-BSA). These IgA anti-PC-BSA immune complexes activated the alternative complement pathway in mouse and guinea pig serum, while human complement was not affected. The activation proceeded with consumption of C3 but little or no consumption of C5. C3 did not bind to the IgA immune complexes during complement activation although it did bind covalently to IgG immune complexes. It is suggested that IgA immune complexes do not supply a suitable surface for C3 binding and effective alternative pathway convertase assembly; therefore, cleavage is limited and occurs primarily in the fluid phase. Without C3 binding, C5 cleavage does not occur nor can the alternative pathway activation proceed to the amplification step. The Rockefeller University Press 1982-01-01 /pmc/articles/PMC2186569/ /pubmed/7054357 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes
title Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes
title_full Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes
title_fullStr Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes
title_full_unstemmed Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes
title_short Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes
title_sort activation of the guinea pig alternative complement pathway by mouse iga immune complexes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186569/
https://www.ncbi.nlm.nih.gov/pubmed/7054357